Vous avez cherché: suitable patients (Anglais - Slovène)

suitable
primeren

suitable devices
ustrezne naprave

suitable thermocouples.
primerna termočlena.

suitable respirometer;
ustrezni respirometer;

wear suitable gloves
uporabljajte ustrezne rokavice.

this medicine may not be suitable for the following patients.
to zdravilo morda ne bo primerno za naslednje bolnike.

wear suitable gloves'
uporabljajte ustrezne rokavice."

wear suitable gloves.’
uporabite primerne zaščitne rokavice.“

suitable constituent materials
ustrezni sestavni materiali

suitable extinguishing media,
ustreznih sredstev za gašenje,

suitable extinguishing media:
ustrezna sredstva za gašenje:

suitable gas chromatography conditions
ustrezne razmere za plinsko kromatografijo

lamivudine teva is not suitable for patients who require doses below 100 mg.
zdravilo lamivudin teva ni primerno za bolnike, ki morajo jemati odmerek, manjši od 100 mg.

guidance on the selection of suitable patients for treatment with glybera including:
smernice o izbiri primernih bolnikov za zdravljenje z zdravilom glybera, vključno s:

emtriva 200 mg hard capsules are only suitable for patients who weigh at least 33 kg.
emtriva 200 mg trde kapsule so primerne le za bolnike, ki tehtajo najmanj 33 kg.

rebetol is also not suitable for patients with certain other past or present serious illnesses.
zdravilo rebetol tudi ni primerno za bolnike z nekaterimi drugimi resnimi sedanjimi ali preteklimi boleznimi.

these are only suitable for patients who weigh at least 33 kg and can swallow hard capsules.
te so primerne samo za bolnike, ki tehtajo najmanj 33 kg in ki lahko pogoltnejo trdo kapsulo.

guidance on the selection of suitable patients for maci treatment and the importance of using maci only in the approved indication
navodila za izbiro primernih bolnikov za zdravljenje z zdravilom maci in pomen uporabe zdravila maci samo v odobreni indikaciji.

dynepo may not be suitable for patients under 18 years old, or for patients with renal or liver problems.
dynepo utegne biti neprimeren za bolnike, mlajše od 18 let, in za bolnike, ki imajo težave z ledvicami ali jetri.

prolonged-release tablets are not suitable for the 14-day lead-in phase for patients starting nevirapine.
tablete s podaljšanim sproščanjem niso primerne za zdravljenje v 14-dnevnem uvajalnem obdobju pri bolnikih, ki začnejo jemati nevirapin.